Skip to content
Riskpilot
← Back to search
Sign in
Get full access
PHARMA-VINCI HOLDING A/S
A/S
Dissolved
CVR 21280607
Undalsvej 6, 3300
Frederiksværk
Undifferentiated goods- and service-producing activities of private households for own use
·
NACE 9800
Est. 1998 · 28 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Undifferentiated goods- and service-producing activities of private households for own use
/
PHARMA-VINCI HOLDING A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (3)
OK
Ole Koch
Chief Executive Officer
Chief Executive Officer
2001 – 2004
NV
Nils Villadsen Nielsen
Management
Management
1998 – 1999
TS
Tina Sandström
Management
Management
1999 – 2001
Board of directors
Non-executive oversight
Name
Role
Member since
Former (13)
JK
Jan Konieczny
Board of Directors
Board of Directors
1998 – 1999
FG
Fernando Gómez González
Board of Directors
Board of Directors
1999 – 2000
AM
Armando Murbartian Del Angel
Board of Directors
Board of Directors
2000 – 2003
MR
Michael Rasmussen
Board of Directors
Board of Directors
1998 – 1999
DN
Daniel Novoa Villasenor
Board of Directors
Board of Directors
1999 – 2000
SP
Svenn Poulsen
Board of Directors
Board of Directors
1999 – 2003
JJ
Jens Josefsen
Board of Directors
Board of Directors
2003 – 2004
AK
Anders Kristian Worsøe
Board of Directors
Board of Directors
2003 – 2004
LM
Lic. Manuel Avelino Martinez
Board of Directors
Board of Directors
2003 – 2004
JT
Jesper Trommer Volf
Board of Directors
Board of Directors
1999 – 2003
JH
Jørgen Hauch Schiøtz
Board of Directors
Board of Directors
1998 – 1999
MM
Manolo Martinez
Board of Directors
Board of Directors
1999 – 2000
PD
Preben Daltoft
Chairman
Chairman
2003 – 2004
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on PHARMA-VINCI HOLDING A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network